Skip to main content

Plakous Therapeutics looks to raise $10M for regenerative medicine drug after getting $310,000 from NC Biotech

After receiving over $300,000 from the N.C. Biotechnology Center, Winston-Salem regenerative medicine startup Plakous Therapeutics is now looking to raise $10 million in equity. CEO Robert Boyce said that this funding will help advance Plakous' medicine through various testing and studies with the goal of beginning a human trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.